Skip to main content
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
129.26
+1.51 (1.18%)
At close: Apr 28, 2026, 4:00 PM EDT
128.32
-0.94 (-0.73%)
After-hours: Apr 28, 2026, 5:27 PM EDT

Gilead Sciences Product Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
HIV
20.75B 20.40B 20.20B 19.86B 19.61B 18.85B 18.45B 18.33B
HIV Growth
5.82% 8.23% 9.50% 8.34% 7.90% 3.28% 2.06% 3.68%
Oncology
3.24B 3.24B 3.27B 3.26B 3.29B 3.21B 3.16B 3.05B
Oncology Growth
-1.61% 0.81% 3.19% 6.75% 12.18% 15.46% 22.16% 27.71%
Liver Disease
3.22B 3.09B 3.01B 3.04B 3.02B 2.99B 2.97B 2.85B
Liver Disease Growth
6.45% 3.27% 1.31% 6.92% 8.55% 7.43% 3.42% 0.21%
Veklury
912.00M 1.04B 1.45B 1.55B 1.80B 2.18B 2.13B 2.17B
Veklury Growth
-49.28% -52.45% -31.67% -28.70% -17.71% -11.52% -22.84% -26.37%
Other
800.00M 779.00M 796.00M 874.00M 889.00M 906.00M 921.00M 884.00M
Other Growth
-10.01% -14.02% -13.57% -1.13% 3.49% -0.44% 3.02% -2.54%

Revenue by Type
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
28.92B 28.55B 28.72B 28.58B 28.61B 28.14B 27.62B 27.28B
Product Growth
1.07% 1.44% 3.96% 4.77% 6.22% 3.48% 1.63% 1.94%
Other
527.00M 538.00M 144.00M 158.00M 143.00M 155.00M 181.00M 175.00M
Other Growth
268.53% 247.10% -20.44% -9.71% -21.43% -19.69% -9.95% -39.24%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.